Repligen's settlement with BMY included belatacept as well as Orencia. So maybe they will get some token revenue from belatacept as well before the expiration of the royalty term.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.